# name
Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain

# metadata.dc.description.abstract[].value
In Spain it is necessary to conduct additional studies to determine place in therapy and cost-effectiveness of a drug. The main objective of this study is to identify all drug assessments and health technology assessment reports of the drugs for gastroenteropancreatic (GEP) neuroendocrine tumors (NET) at a national, regional and hospital level and to summarize the efficacy in terms of outcome measures, adverse events, economic impact and final recommendations.

# metadata.dc.relation.ispartof[].value
Neuroendocrinology Letters, 2019, vol. 39, num. 8, p. 537-543

# metadata.dc.source[].value
Articles publicats en revistes (Economia)

# metadata.dc.title[].value
Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in Spain